In clinics, AD biomarkers such as cerebrospinal fluid Aß42 and Tau can be detected decades before the onset of AD dementia (Sperling et al., 2011; Bateman et al., 2012; Buchhave et al., 2012). The gene discussed is MAPT; the disease is Alzheimer disease.